Ultrasmall iron oxide particle contrast agent and MRI can be used to monitor the effect of anti-rejection treatment

Transplantation

Volumn 84, Issue 3, 2007, Pages 374-379

  Penno, Eva ^a   Johansson, Lars ^a   Ahlström, Håkan ^a   Johnsson, Cecilia ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute rejection; Contrast agent; Experimental heart transplantation; Magnetic resonance imaging

Indexed keywords

CONTRAST MEDIUM; CYCLOSPORIN A; INTRALIPID; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CALCULATION; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; MALE; MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SIGNAL DETECTION;

ADMINISTRATION, ORAL; ANIMALS; CONTRAST MEDIA; CYCLOSPORINE; FAT EMULSIONS, INTRAVENOUS; FERRIC COMPOUNDS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MICROSPHERES; MYOCARDIUM; RATS; RATS, INBRED WKY;

EID: 34547889906     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000276957.62313.fe     Document Type: Article

References (25)

1. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 2004; 23: 796.
2. Mehra MR, Uber PA, Uber WE, Park MH, Scott RL. Anything but a biopsy: Noninvasive monitoring for cardiac allograft rejection. Curr Opin Cardiol 2002; 17: 131.
3. Turetschek K, Huber S, Floyd E, et al. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 2001; 218: 562.
4. Daldrup-Link HE, Rydland J, Helbich TH, et al. Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: Initial phase II multicenter trial. Radiology 2003; 229: 885.
5. Sigal R, Vogl T, Casselman J, et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall super-paramagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur Radiol 2002; 12: 1104.
6. Bellin MF, Lebleu L, Meric JB. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging 2003; 28: 155.
7. Sadowski EA, Fain SB, Alford SK, et al. Assessment of acute renal transplant rejection with blood oxygen level-dependent MR imaging: Initial experience. Radiology 2005; 236: 911.
8. Yang D, Ye Q, Williams DS, Hitchens TK, Ho C. Normal and transplanted rat kidneys: Diffusion MR imaging at 7 T. Radiology 2004; 231: 702.
9. Klemm A, Rzanny R, Funfstuck R, et al. 31P-magnetic resonance spectroscopy (31P-MRS) of human allografts after renal transplantation. Nephrol Dial Transplant 1998; 13: 3147.
10. Grist TM, Charles HC, Sostman HD. 1990 ARRS Executive Council Award. Renal transplant rejection: Diagnosis with 31P MR spectroscopy. AJR Am J Roentgenol 1991; 156: 105.
11. Wang JJ, Hendrich KS, Jackson EK, Ildstad ST, Williams DS, Ho C. Perfusion quantitation in transplanted rat kidney by MRI with arterial spin labeling. Kidney Int 1998; 53: 1783.
12. Ye Q, Yang D, Williams M, et al. In vivo detection of acute rat renal allograft rejection by MRI with USPIO particles. Kidney Int 2002; 61: 1124.
13. Kanno S, Wu YJ, Lee PC, et al. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001; 104: 934.
14. Kanno S, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J Thorac Cardiovasc Surg 2000; 120: 923.
15. Johansson L, Johnsson C, Penno E, Bjornerud A, Ahlstrom H. Acute cardiac transplant rejection: detection and grading with MR imaging with a blood pool contrast agent-experimental study in the rat. Radiology 2002; 225: 97.
16. Penno E, Johnsson C, Johansson L, Ahlstrom H. Comparison of ultrasmall superparamagnetic iron oxide particles and low molecular weight contrast agents to detect rejecting transplanted hearts with magnetic resonance imaging. Invest Radiol 2005; 40: 648.
17. Olausson M, Mjornstedt L, Lindholm L, Brynger H. Non-suture organ grafting to the neck vessels in rats. Acta Chir Scand 1984; 150: 463.
18. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York, London.: Chapman and Hall, 1993.
19. Ho C, Hitchens TK. A non-invasive approach to detecting organ rejection by MRI: Monitoring the accumulation of immune cells at the transplanted organ. Curr Pharm Biotechnol 2004; 5: 551.
20. Wu YL, Ye Q, Foley LM, et al. In situ labeling of immune cells with iron oxide particles: An approach to detect organ rejection by cellular MRI. Proc Natl Acad Sci U S A 2006; 103: 1852.
21. Mazzucchi E, Lucon AM, Nahas WC, et al. Histological outcome of acute cellular rejection in kidney transplantation after treatment with methylprednisolone. Transplantation 1999; 67: 430.
22. Engstrand M, Johnsson C, Larsson E, Tufveson G, Korsgren O. Quantification of lymphocytes propagating from rat-kidney allografts-a tool to monitor anti-rejection treatment. Transpl Immunol 2002; 10: 31.
23. Onishi H, Murakami T, Kim T, et al. Hepatic metastases: Detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 2006; 239: 131.
24. Kalber TL, Smith CJ, Howe FA, et al. A longitudinal study of R2* and R2 magnetic resonance imaging relaxation rate measurements in murine liver after a single administration of 3 different iron oxide-based contrast agents. Invest Radiol 2005; 40: 784.
25. Allkemper T, Heindel W, Kooijman H, Ebert W, Tombach B. Effect of field strengths on magnetic resonance angiography: Comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla. Invest Radiol 2006; 41: 97.